Global CRO Quintiles has launched the Quintiles Emerging Biopharma Solution, a new offering designed to meet the unique clinical development needs and goals of emerging biopharmaceutical companies in the global marketplace.
The solution is a newly developed operating model aligned with customer needs within this segment and leverages Quintiles' integrated technology platforms to provide customers with real-time data access as well as a transparent view of project performance. In addition to providing a dedicated leader with emerging biopharmaceutical operations expertise, the offering includes senior-level sponsorship for each customer. This level of support provides easy access to the unique expertise and nimble operational support required by these companies.
The new offering covers all therapeutic areas and adds to the oncology experience of Novella Clinical, Quintiles' oncology service provider for emerging biopharmaceutical customers.